Sun Biomedical Technologies researchs on early genetic responses to infectious diseases and environmental hazards, as well as development of peptide antibiotics for use as a Bacillus spore decontaminating agents, as detectors for Bacillus spores, and for potential treatment of anthrax spore inhalation and infection